NEOVASC INC Income Statement | Understand Stock

Ask AI

Financial Statements

In millions of USD, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
REVENUE
Reducer
REVENUE
COST OF GOODS SOLD
GROSS PROFIT

EXPENSES
Selling expenses
General and administrative expenses
Product development and clinical trials expenses
TOTAL EXPENSES
OPERATING LOSS
OTHER INCOME/ (EXPENSE)
Interest expense
Interest and other income
Interest and other expense
Impairment on right-of-use asset
Gain on sale of assets
Loss on foreign exchange
Realized loss on exercise of warrants and convertible note
Unrealized gain/(loss) on warrants, derivative liability warrants and convertible notes
Realized (loss)/gain on exercise or conversion of warrants, derivative liability warrants and convertible notes
Amortization of deferred loss
TOTAL OTHER INCOME/ (EXPENSE)
LOSS BEFORE TAX
Tax (expense)/recovery
LOSS FOR THE YEAR

OTHER COMPREHENSIVE (LOSS)/INCOME FOR THE YEAR
Fair market value changes in convertible note due to changes in own credit risk
TOTAL OTHER COMPREHENSIVE INCOME FOR THE YEAR
LOSS AND OTHER COMPREHENSIVE LOSS FOR THE YEAR
LOSS PER SHARE
Basic loss per share
Diluted loss per share

Comments